Sage Therapeutics Inc. News
Biogen Beats on Third Quarter Earnings and Raises Guidance
Biogen posts third-quarter earnings that beat forecasts and also ups its full-year profit forecast amid strong expected demand for its Alzheimer's treatment drug.
Premarket Movers Tuesday: Sage Therapeutics, MicroStrategy
Stocks moving in premarket trading Tuesday include Sage Therapeutics, Freeport-McMoRan, MicroStrategy, ContextLogic and Fastenal.
Sage Therapeutics Plunges After Depression Drug-Trial Results
Sage Therapeutics shares plunge following disappointing test results for its depression drug Zuranolone that it is producing with drug giant Biogen.
Sage Falls as Some Patients Drop Out of Tremor Treatment Study
Nearly 40% of patients left a Sage Therapeutics study of a treatment for tremors due to side effects.
Sage Therapeutics Rises After Swing to Profit on Biogen Deal
Sage Therapeutics traded higher after the biopharma posted a fourth-quarter profit, benefiting from its collaboration with Biogen.
Roe Decision Forces Disney, Netflix to Take a Political Stand
Disney, JP Morgan Chase, and outgoing Meta COO Sheryl Sandberg are just a few speaking out against the ruling.
Netflix Lays Offs More Employees To Cut Costs
Netflix layoffs continue as the streaming giant executes a plan to cope with slow revenue growth.
These Five Things Could Help (or Hurt) Internet Stocks
Bank of America analysts outline some of the biggest issues facing Amazon, Alphabet, Meta and other internet-related stocks.